معرفی
Dr. Esteban Cruz Gonzalez is a **Research Fellow** at the **Queensland Brain Institute (QBI)**, University of Queensland. His research focuses on neurodegenerative diseases, particularly Alzheimer's, with an emphasis on tau protein mechanisms, immunotherapy strategies, and innovative drug delivery systems using ultrasound and monoclonal antibodies. He leads projects investigating tau proteostasis, protein aggregation dynamics, and enhancing therapeutic efficacy through advanced biopharmaceutical approaches.
His work bridges molecular biology, biomedical engineering, and clinical applications. Key research areas include:
- **Tau Immunotherapy**: Investigating tau protein behavior and developing antibodies targeting pathological tau aggregates.
- **Ultrasound-Mediated Delivery**: Optimizing focused ultrasound to enhance brain penetration of biologics across the blood-brain barrier.
- **Protein Engineering**: Improving antibody stability and glycosylation profiles to enhance therapeutic performance.
Dr. Gonzalez collaborates with multidisciplinary teams, integrating structural biology, nanotechnology, and in vitro models to advance treatments for neurodegenerative disorders. His recent studies highlight the role of tau phosphorylation and plasma membrane interactions in disease progression.
He has published extensively in journals like Brain, Molecular Brain, and Advanced Drug Delivery Reviews, contributing to both foundational science and translational medicine.
